27 Jan 2021 – Destiny Pharma welcomes Matt Hancock’s statement saying G7 will focus on AMR

Destiny Pharma welcomes Matt Hancock’s attention to antimicrobial resistance within his speech on the UK taking presidency of the G7.

Mr Hancock states “This is a matter of driving forward progress that is already being made. The silent pandemic of antimicrobial resistance, especially bacterial resistance will have consequences that are just as deadly as COVID-19, over a longer timeframe, if we don’t act now”.

Please follow link below for full speech:


#AntimicrobialResistance #AMR #DrugDiscovery #G7